Lessons learned from 2 patients with multidrug-resistant HIV-1 infection successfully treated with a darunavir-containing antiretroviral treatment regimen
Faculty of Medicine and Health Sciences
Journal of the International Association of Physicians in AIDS Care. - Chicago, Ill.
, p. 203-205
University of Antwerp
The authors describe 2 patients with life-threatening multidrug-resistant HIV-1 infection who responded very well to a treatment regimen containing darunavir and enfuvirtide. They discuss the availability of several new treatment options such as darunavir, etravirine, integrase, and CCR5 inhibitors for patients with multidrug-resistant viruses.